Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-013706-13Phase 4Completed
Phase 4, open-label, single-arm trial of lidocaine in diabetic polyneuropathy (DPN), sponsored by Klinik Ottakring. Primary endpoints: Global patient treatment satisfaction and Good treatment responder rate. Started Nov 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-013706-13.